20
Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EZETIMIBE, with a corresponding US DMF Number 24511.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2015, and payment made on September 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II